The rapid development of targeted cancer therapies across cancer types has improved patient survival and quality of life. Many of these advances depend on access to comprehensive biomarker testing. The Montana-Wyoming Cancer Summit will explore the importance of improving patient access to precision medicine and biomarker testing in Montana and Wyoming.